GlassScriptPhysician profile
Catherine Ann Chartier
NPI 1497730618
$2,118.94
in general payments reported to CMS, 2019-2025
31 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $151 · 2021: $254 · 2022: $427 · 2023: $548 · 2024: $257 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $978.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $978.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $343.93 | 2019-2025 | Liletta |
| Sumitomo Pharma America, INC. | $205.70 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $190.51 | 2023-2025 | Veozah, Myrbetriq |
| Amgen INC. | $168.01 | 2019-2024 | Prolia, Evenity |
| Boston Scientific Corporation | $109.99 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Hologic Sales and Service, LLC | $109.37 | 2020-2024 | Acessa Provu System, Novasure |
| Mayne Pharma Commercial LLC | $102.07 | 2021-2024 | |
| Myovant Sciences INC. | $97.52 | 2021-2022 | |
| Pfizer INC. | $93.21 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $78.08 | 2019-2025 | |
| Mylan Pharmaceuticals INC. | $70.23 | 2019-2022 | |
| Coopersurgical, INC. | $51.31 | 2019-2021 | |
| Exeltis, USA INC. | $43.14 | 2021-2022 | |
| Sage Therapeutics, LLC | $41.92 | 2024-2025 | Zurzuvae |
| Daiichi Sankyo INC. | $41.28 | 2022-2023 | Injectafer |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $38.32 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $36.23 | 2019-2020 | |
| Channel Medsystems, INC. | $34.43 | 2023 | |
| Lupin INC. | $31.37 | 2019 | |
| Agile Therapeutics, INC. | $29.41 | 2022-2023 | Twirla |
| Avion Pharmaceuticals | $24.93 | 2019 | |
| Therapeuticsmd, INC. | $22.74 | 2022 | |
| Duchesnay USA Incorporated | $22.72 | 2019 | |
| Smith+Nephew, INC. | $21.49 | 2022 | |
| Gynesonics, INC. | $20.49 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $20.12 | 2023 | Nexplanon |
| Bard Access Systems, INC. | $17.20 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.68 | 2023 | Exparel |
| Meditrina | $13.78 | 2023 | |
| Amag Pharmaceuticals, INC. | $13.49 | 2019 | |
| Merck Sharp & Dohme LLC | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Chartier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.